A detailed history of Arizona State Retirement System transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 23,367 shares of VKTX stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,367
Previous 23,768 1.69%
Holding current value
$1.2 Million
Previous $442,000 333.48%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$17.4 - $94.5 $6,977 - $37,894
-401 Reduced 1.69%
23,367 $1.92 Million
Q4 2023

Jan 24, 2024

SELL
$9.24 - $19.64 $16,789 - $35,685
-1,817 Reduced 7.1%
23,768 $442,000
Q3 2023

Nov 06, 2023

SELL
$10.92 - $16.0 $10,778 - $15,792
-987 Reduced 3.71%
25,585 $283,000
Q2 2023

Aug 01, 2023

BUY
$14.84 - $24.79 $97,558 - $162,969
6,574 Added 32.87%
26,572 $430,000
Q1 2023

Apr 27, 2023

BUY
$8.08 - $17.33 $161,583 - $346,565
19,998 New
19,998 $332,000
Q2 2022

Jul 28, 2022

SELL
$2.11 - $3.15 $40,159 - $59,953
-19,033 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$3.0 - $4.88 $279 - $453
93 Added 0.49%
19,033 $57,000
Q4 2021

Feb 04, 2022

SELL
$4.6 - $6.72 $947 - $1,384
-206 Reduced 1.08%
18,940 $87,000
Q3 2021

Nov 12, 2021

BUY
$5.58 - $7.04 $6,885 - $8,687
1,234 Added 6.89%
19,146 $120,000
Q2 2021

Aug 02, 2021

SELL
$5.19 - $6.73 $6,233 - $8,082
-1,201 Reduced 6.28%
17,912 $107,000
Q1 2021

May 06, 2021

BUY
$5.74 - $9.67 $820 - $1,382
143 Added 0.75%
19,113 $121,000
Q4 2020

Jan 28, 2021

SELL
$5.3 - $6.71 $3,943 - $4,992
-744 Reduced 3.77%
18,970 $107,000
Q3 2020

Nov 05, 2020

BUY
$5.73 - $8.11 $28,501 - $40,339
4,974 Added 33.74%
19,714 $115,000
Q2 2020

Aug 04, 2020

SELL
$4.35 - $8.08 $2,296 - $4,266
-528 Reduced 3.46%
14,740 $106,000
Q1 2020

May 05, 2020

BUY
$3.45 - $7.95 $52,674 - $121,380
15,268 New
15,268 $71,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.95B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.